Waltham, MA - Nova Biomedical announces the addition of C-reactive protein (CRP) testing to
its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings. The
Allegro and its StatStrip companion meter provides 11 clinically important tests to help
physicians make therapeutic decisions and adjustments during the patient visit. The Allegro
analyzer and this new CRP test are available in CE regulated countries. Allegro will be submitted
to the U.S. FDA for CLIA waived use.
CRP is a protein made by the liver and is sent into the bloodstream in response to inflammation.
Allegro’s CRP test measures the amount of CRP in whole blood to detect inflammation due to
acute conditions such as infection or to monitor chronic conditions including cardiovascular
disease and autoimmune disease. CRP is just one of 11 tests for the Allegro platform, including
glycated hemoglobin (HbA1c), Total Cholesterol, HDL Cholesterol, LDL Cholesterol
Triglyceride, Glucose, Blood Creatinine, PT/INR, Urine Albumin and Urine Creatinine.
Allegro tests use capillary fingerstick samples for all tests, eliminating the need for venipuncture
or a trained phlebotomist. All tests use disposable test cartridges or strips. Allegro’s quick six to
nine-minute cartridge test times, less than 30 second test strip times, and ability to measure two
cartridges simultaneously provide rapid results immediately to the physician during the patient
visit. Having immediate results during the patient visit simplifies workflow and reduces clinic
follow-up calls, letters, and patient re-visits, and improves patient compliance with care plans.